Abstract. MAIA, Ana Luiza et al. Diagnóstico, tratamento e seguimento do carcinoma medular de tireoide: recomendações do Departamento de Tireoide da . ARTIGO ORIGINAL. Rastreamento genético do carcinoma medular de tireóide: identificação de mutações no proto-oncogene ret. Molecular screening of. Resumo. O Carcinoma medular da tiroide (CMT) é um tumor neuroendócrino raro (% de todos os tumores da tiroide), que surge a partir de células C.
|Published (Last):||12 February 2014|
|PDF File Size:||15.71 Mb|
|ePub File Size:||2.72 Mb|
|Price:||Free* [*Free Regsitration Required]|
Chemoembolization for liver metastases from medullary thyroid carcinoma.
Lessons learned from the management of a rare genetic cancer. Multivariate analysis of patients with medullary thyroid carcinoma.
Tratamento do Carcinoma Medular da Tiroide
Approach to the thyroid cancer patient with bone metastases. Application Visibility and Control B. Atinge igualmente ambos os sexos. Takahashi M, Cooper GM.
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer. Mmedular fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: Preoperative diagnosis of medullary thyroid carcinoma: Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer. RET codon mutations in multiple endocrine neoplasia type 2: Quando devemos suspeitar do CMT?
The present article discusses the clinical and molecular diagnosis, initial surgical treatment, and postoperative management of MTC, as well as the therapeutic options for metastatic caricnoma.
Carcinoma Medular da Tiroide – perspetiva após as guidelines de 2015 da ATA
Current approaches to medullary thyroid carcinoma, sporadic and familial. Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: Clinically unpredictable prognostic factors in the outcome of medullary thyroid cancer.
Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases. Prediction of lateral lymph node metastases in tireolde thyroid cancer.
It provides clientless remote access to multiple network-based systems. Contralateral cervical and mediastinal lymph node metastasis in medullary thyroid cancer: Disease associated mutations at valine in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors.
Hum Molec Genet ; 3: A nationwide study of patients in Sweden from through Association of multiple endocrine neoplasia type 2 sa Hirschsprung disease. Goldman L and Schafer AI. Hum Mol Genet ;3: Comparison of two provocative tests for calcitonin in medullary thyroid carcinoma: Mutation analysis of the RET proto-oncogene and early thyroidectomy: Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Medullary thyroid carcinoma: clinical and oncological features and treatment
Am J Hum Genet ; All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License. DNA sequencing with chain terminationo inhibitors.
O preparo para a cirurgia deve ser individualizado de acordo com a sintomatologia do paciente. Measuring calcitonin in washout of the needle in patients undergoing fine needle aspiration with suspicious medullary thyroid tireoidw.
Germ-line mutation of the RET proto-oncogene in multiple endocrine neoplasia type 2a.
Schimke RN Genetic aspects of multiple endocrine neoplasia. The present article describes clinical evidence-based guidelines for the diagnosis, treatment, and follow-up of MTC. Molecular basis of medullary thyroid carcinoma: Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism.
Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.